What do the lab results (hemoglobin 10.2 g/dL, low mean corpuscular hemoglobin, low mean corpuscular hemoglobin concentration, platelet count 408 ×10⁹/L) indicate in a 37‑year‑old woman with a history of iron‑deficiency anemia?

Interpretation of Laboratory Results in a 37-Year-Old Woman with Known Iron Deficiency Anemia

Direct Interpretation

These laboratory values confirm active microcytic, hypochromic iron deficiency anemia with reactive thrombocytosis. 1

---

Laboratory Value Analysis

Anemia Confirmation

• Hemoglobin 10.2 g/dL is below the normal threshold for adult women (typically <12 g/dL defines anemia), confirming the presence of anemia. 1
• This hemoglobin level in a premenopausal woman warrants investigation, though it does not yet meet the threshold for "urgent" evaluation (Hb <10 g/dL in postmenopausal women is considered more urgent). 2

Microcytic, Hypochromic Pattern

• MCH 23.7 pg (normal range ~27-31 pg) indicates microcytic anemia—the red blood cells contain less hemoglobin than normal. 3
• MCHC 30.8 g/dL (normal range ~32-36 g/dL) confirms hypochromic anemia—the red blood cells have reduced hemoglobin concentration. 3
• These findings are classic for iron deficiency anemia, as insufficient iron prevents adequate hemoglobin synthesis within developing red blood cells. 1, 4

Reactive Thrombocytosis

• Platelet count 408 × 10⁹/L (normal range ~150-400 × 10⁹/L) represents mild thrombocytosis. 5
• Thrombocytosis occurs in 13-28% of patients with iron deficiency anemia and is a well-documented reactive phenomenon. 6, 7
• The mechanism involves inverse correlation between serum iron/transferrin saturation and platelet count—the more severe the iron deficiency, the higher the platelet count. 5, 3
• Platelet counts inversely correlate with hemoglobin, hematocrit, and MCHC levels in iron deficiency. 3
• This thrombocytosis is reactive and typically resolves with iron repletion therapy. 5

---

Clinical Significance & Next Steps

Confirm Iron Deficiency

• Serum ferritin is the single most useful marker to confirm iron deficiency; a level <30 μg/L (or <15 μg/L in some guidelines) confirms absolute iron deficiency. 1, 4
• If ferritin is equivocal, transferrin saturation <20% supports the diagnosis. 1
• A hemoglobin rise ≥10 g/L within 2 weeks of starting iron therapy is highly suggestive of iron deficiency even if iron studies are borderline. 1

Identify the Underlying Cause

In a 37-year-old premenopausal woman, the most common cause is menstrual blood loss, but other etiologies must be excluded. 2

Essential Initial Workup:

• Detailed menstrual history: assess for menorrhagia (heavy menstrual bleeding), which is the leading cause in this demographic. 1
• Dietary history: evaluate for inadequate iron intake (vegetarian/vegan diet, restrictive eating). 2
• Gastrointestinal symptoms: screen for occult GI blood loss (melena, hematochezia, chronic NSAID use, peptic ulcer symptoms). 1, 2
• Urinalysis or urine microscopy: exclude hematuria as a source of blood loss. 1
• Celiac disease screening: serologic testing (tissue transglutaminase IgA with total IgA) is recommended in all adults with iron deficiency anemia, as celiac disease accounts for 3-5% of cases. 1, 2

When to Pursue GI Investigation:

• If menstrual blood loss does not fully explain the anemia, or if there are any GI symptoms, bidirectional endoscopy (upper endoscopy and colonoscopy) is indicated to exclude GI malignancy and other pathology. 1, 2
• In premenopausal women, GI investigation is typically reserved for those with alarm symptoms (weight loss, GI bleeding, family history of GI cancer) or refractory anemia despite adequate iron replacement and menstrual management. 1
• Postmenopausal women and men with new iron deficiency anemia require urgent bidirectional endoscopy regardless of symptoms, as approximately one-third have underlying GI pathology, including malignancy. 1, 2

---

Treatment Approach

Iron Replacement Therapy

• Initiate oral iron supplementation (e.g., ferrous sulfate 325 mg daily to three times daily, or equivalent elemental iron 100-200 mg/day). 1
• Recheck hemoglobin in 2 weeks: a rise of ≥10 g/L confirms response and supports the diagnosis. 1
• Continue iron therapy for 3-6 months after hemoglobin normalization to replete iron stores. 1, 4
• Intravenous iron is reserved for patients intolerant of oral iron, malabsorption, or refractory anemia. 1

Monitor Platelet Count

• Platelet count will normalize with iron repletion; no specific intervention for thrombocytosis is needed. 5
• Mild reactive thrombocytosis in iron deficiency does not increase thrombotic risk and does not require antiplatelet therapy. 5

---

Common Pitfalls

• Do not assume menstrual blood loss is the sole cause without confirming iron deficiency biochemically and excluding other sources. 1
• Do not overlook celiac disease screening—it is found in 3-5% of iron deficiency anemia cases and is easily missed. 1, 2
• Do not stop investigation after finding one lesion in older patients or those with severe anemia, as dual pathology (simultaneous upper and lower GI sources) occurs in 1-10% of cases. 2
• Do not use fecal occult blood testing to decide whether to pursue endoscopy in established iron deficiency anemia—it may delay definitive diagnosis. 2